2016 Prevention Gap Report
Analysis of evidentiary value
This report was issued by the Secretariat of the Joint Programme in the United Nations on HIV/AIDS (UNAIDS)–a coalition of 11 UN agencies and the World Bank helping to coordinate the global AIDS response by engaging with governments, civil society and people living with HIV.
UNAIDS is overseen by a Programme Coordinating Board composed of representatives from 22 geographically diverse countries; the 11 UN agencies, including the World Health Organization, UN Women, and the United Nations Population Fund; and five nongovernmental organisations. UNAIDS is the only UN entity that has representatives of civil society on its board.
This report is based on evidence from 146 countries over the last 10 years and explores the proven ties between HIV prevention and inequality.
Used as precedent
key and vulnerable populations
“Recent studies suggest that people who inject drugs are 24 times more likely to acquire HIV than adults in the general population, sex workers are 10 times more likely to acquire HIV and gay men and other men who have sex with men are 24 times more likely to acquire HIV. In addition, transgender people are 49 times more likely to be living with HIV and prisoners are five times more likely to be living with HIV than adults in the general population.” (p. 7)
“Among gay men and other men who have sex with men, in 7 of 10 countries with available data, treatment coverage was considerably lower than coverage among all men living with HIV. Treatment coverage levels among people who inject drugs were more similar to coverage among men generally, but differences were still observed in 4 of 8 countries. Female sex workers were also less likely to access treatment than the general adult female population, with just 3 of 12 countries having similar levels of coverage. In Cambodia, transgender people had higher treatment coverage than female sex workers but lower than the general adult female population.” (p. 57)
combination prevention
“However, few countries have consistently applied a combination HIV prevention approach, which provides packages of services—including behavioural, biomedical and structural components—tailored to priority population groups within their specific local contexts. For example, young people in high prevalence countries need more than condoms and behaviour change communications. They also require comprehensive sexuality education and access to effective HIV and sexual and reproductive health services without economic barriers, such as prohibitive costs, or structural barriers, such as parental consent laws. A combination package for gay men and other men who have sex with men should include easy access to condoms, lubricant and PrEP, as well as efforts to address homophobia; a package for people who inject drugs should feature comprehensive harm reduction services, including needle-syringe programmes and opioid substitution therapy.” (p. 10)
“Getting back on track to reducing new infections to 500 000 by 2020 requires continued progress towards the 90–90–90 target and intensive focus on five prevention pillars delivered through a people-centred, combination approach:Combination prevention, including comprehensive sexuality education, economic empowerment and access to sexual and reproductive health services for young women and adolescent girls and their male partners in high-prevalence locations.” (p. 10)
“Individual harm reduction approaches are successful in reducing the harms related to drug use, but they are even more effective when delivered as a package, not only together but combined with other prevention services such as condom programmes and treatment. Condom provision within harm-reduction programmes can help to reduce the transmission of HIV from people who inject drugs to their sexual partners. Ensuring HIV tests are offered routinely to people who access needle-syringe services and opioid substitution therapy helps to identify people living with HIV as soon as possible after infection and the immediate initiation of antiretroviral therapy. People living with HIV who inject drugs are more likely to remain on antiretroviral therapy if they are also accessing opioid substitution therapy; in addition, early initiation of treatment contributes to the suppression of viral load and maximizes the prevention benefits of such treatment. Increasing the provision of such combined approaches—including those that incorporate pre-exposure prophylaxis for people who inject drugs at particularly high risk, and for their sexual partners—will enhance the benefits of harm reduction.” (p. 52)
gender equality
“Experiences of physical and emotional intimate partner violence in settings with male controlling behaviour and HIV prevalence above 5% have been strongly associated with HIV infection in women. In some regions, women who experienced physical or sexual intimate partner violence were 1.5 times more likely to acquire HIV than women who had not experienced violence.” (p. 20)
“Studies have shown that increasing educational achievement among women and girls is linked to better sexual and reproductive health outcomes, including lower rates of HIV infection, delayed childbearing, safer births and safer abortions, and other development outcomes.” (p. 23)
negative legal determinants
“For example, when possession of injecting equipment or condoms is used by criminal justice systems as evidence of drug use or sex work, people at high risk of HIV infection are less likely to use these proven prevention tools.” (p. 24)
“Criminalization of drug possession and use perpetuates risky forms of drug use, increases HIV risk, discourages people who use drugs from seeking health care, and reinforces the marginalization of people who use drugs. Presently, 11 countries have compulsory detention and 15 have death penalties for people who used drugs.” (p. 44)
“Criminal justice systems that use possession of drug paraphernalia or drug residue within injecting equipment as evidence of illegal drug possession or use are particularly disruptive to needle–syringe programmes. Syringe confiscation has been associated with increases in HIV infection among female sex workers who inject drugs. In parts of eastern Europe and central Asia, nongovernmental organizations report that police may consider needle–syringe distribution as promotion of illegal drug use, which leads to a high rate of turnover among outreach workers who fear they may be arrested for carrying injecting equipment.” (p. 50)
intersectionality
“Women who inject drugs faced higher levels of stigma, discrimination and vulnerability to harm than their male counterparts. Those who had experienced sexual violence were more likely to be living with HIV than other women who inject drugs.” (p. 27)
“HIV prevalence among women who inject drugs is often greater than their male peers, highlighting a need for gender-sensitive harm reduction interventions. In 24 of 35 countries reporting to the 2016 Global AIDS Response Progress Report, median HIV prevalence among women was 50% higher, with a range of 2% to 530%.” (p. 44)
sexual rights
“A modelling study estimated that eliminating sexual violence against sex workers could avert 17% of HIV infections in Kenya and 20% in Canada.” (p. 27)
harm reduction
“Needle-syringe programmes reduce the spread of HIV, hepatitis C and other bloodborne viruses. Opioid substitution therapy and other evidence-informed forms of drug dependence treatment curb drug use, reduce vulnerability to infectious diseases, and improve uptake of health and social services.” (p. 44)
“Decades of experience within dozens of countries supports the effectiveness of needle–syringe programmes. Across eight countries in eastern Europe and central Asia, a tripling of needle–syringe programme coverage between 2005 and 2010 reduced injecting risk behaviour related to HIV and hepatitis C and reduced new infections. Many individual programmes have achieved outstanding results. Ten years of needle–syringe programming in Australia reduced the number of cases of HIV by up to 70% and reduced the number of cases of hepatitis C by up to 43%. In New York a sharp decrease in new HIV infections among people who inject drugs between 1992 and 2012 has been attributed to the implementation and expansion of syringe exchange since 1992.” (p. 46)
“Substitution therapy has also been shown to decrease the risk of hepatitis C infection, to increase adherence to antiretroviral therapy for HIV, to lower out-of-pocket health expenditures, and to reduce opioid overdose risk by almost 90%. The scale-up of methadone maintenance therapy in diverse country contexts, including Portugal, Viet Nam and New Zealand, has also been associated with a decrease in crimes committed by people who use drugs.” (p. 48)
stigma and discrimination
“Among gay men and other men who have sex with men, in 7 of 10 countries with available data, treatment coverage was considerably lower than coverage among all men living with HIV. Treatment coverage levels among people who inject drugs were more similar to coverage among men generally, but differences were still observed in 4 of 8 countries. Female sex workers were also less likely to access treatment than the general adult female population, with just 3 of 12 countries having similar levels of coverage. In Cambodia, transgender people had higher treatment coverage than female sex workers but lower than the general adult female population.” (p. 57)
comprehensive sexuality education
“In sub-Saharan Africa, survey data from 35 countries show that only 36% of young men and 30% of young women correctly identified ways of preventing the sexual transmission of HIV and rejected major misconceptions about HIV transmission. In 23 countries outside of sub-Saharan Africa, just 13.8% of young men and 13.6% of young women had correct and comprehensive knowledge about HIV.” (p. 71)